Sort
16,300 grants matching “fatty liver disease”
BARIATRIC SURGERY CLINICAL RESEARCH CONSORTIUM
$1,072,455Bruce M Wolfe · Oregon Health & Science University · U01 · FY2007 · DK
Integrative Molecular Profiling of Human Pancreatic Cancer
$1,071,845Syed Perwez Hussain · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Pediatric Trials in Non-Alcoholic Steatohepatitis (NASH)
$1,071,590Joel Edward Lavine · University Of California, San Diego · U01 · FY2007 · DK
Aging Intervention Program
$1,070,235Rafael De Cabo · National Institute On Aging · ZIA · FY2024 · AG
Dihydroceramide Desaturase-1 Inhibitors for Treatment of Diabetes and Other Metabolic Diseases
$1,069,999Jeremy Blitzer · Potrero Hill Therapeutics, Inc. · R44 · FY2021 · DK
Dihydroceramide Desaturase-1 Inhibitors for Treatment of Diabetes and Other Metabolic Diseases
$1,069,999Jeremy Blitzer · Potrero Hill Therapeutics, Inc. · R44 · FY2020 · DK
Dihydroceramide Desaturase-1 Inhibitors for Treatment of Diabetes and Other Metabolic Diseases
$1,069,999Jeremy Blitzer · Potrero Hill Therapeutics, Inc. · R44 · FY2022 · DK
Resistance and Cardiorespiratory Time-matched Exercise Training in Youth: A Rando
$1,068,588Sojung Lee · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · HL
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury
$1,067,050Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2011 · AA
Xenobiotic Receptors
$1,064,626Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Analysis of cancer-related immune suppressor mechanisms in mice
$1,064,344Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Overcoming Neurogenic âMeta-Inflammationâ to Promote Recovery After Spinal Cord Injury
$1,064,185Phillip G Popovich · Ohio State University · R35 · FY2024 · NS
Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism
$1,061,357Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2024 · AA
Pennington/Louisiana NORC
$1,061,140Eric Ravussin · Lsu Pennington Biomedical Research Ctr · P30 · FY2016 · DK
Development of PAR2 Pepducins as a Novel NASH Treatment
$1,060,598Athan Kuliopulos · Oasis Pharmaceuticals · R44 · FY2018 · DK
Integrative Molecular Profiling of Human Pancreatic Cancer
$1,057,062Syed Perwez Hussain · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
A Multi-Center Group to Study Acute Liver Failure in Children
$1,056,928Robert H Squires · Children'S Hosp Pittsburgh/Upmc Hlth Sys · U01 · FY2008 · DK
Development of PAR2 Pepducins as a Novel NASH Treatment
$1,056,106Athan Kuliopulos · Oasis Pharmaceuticals · R44 · FY2019 · DK
Resistance and Cardiorespiratory Time-matched Exercise Training in Youth: A Rando
$1,055,593Sojung Lee · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · HL
Biobehavioral Studies of Obesity, Weight loss and Recidivism
$1,055,230Monica Skarulis · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK
CELLULAR PATHOGENESIS OF PEDIATRIC LIVER DISEASE
$1,053,455Washington University · P01 · FY2000 · DK
National Resource for Advanced NMR Technology
$1,052,841Robert Schurko · Florida State University · RM1 · FY2024 · GM
Device Automation of an FDA-cleared CD-Microfluidic Platform for Rapid Tissue Microsizing
$1,050,276Ahmed Nabil Zobi · Syntr Health Technologies, Llc · R44 · FY2025 · TR
Development of PAR2 Pepducins as a Novel NASH Treatment
$1,048,644Athan Kuliopulos · Oasis Pharmaceuticals · R44 · FY2017 · DK
A 3D biomimetic liver sinusoid construct for predicting physiology and toxicity
$1,046,286D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · UH2 · FY2013 · TR